Dr. Jenny Eileen Murase, MD

Dr. Murase practices at Surgery Center Mountain View in Mountain View, California.

Dr. Murase's NPI, 1346371382, was assigned on March 9, 2007. Dr. Murase graduated from UC Irvine School of Medicine in 2003. Dr. Murase holds California license A90118.

Dr. Murase's primary practice is Surgery Center Mountain View, at 701 E. El Camino Real, 1 Northwest, Mountain View, CA 94040. The practice phone is (408) 739-6000.

Dr. Murase's primary practice is Surgery Center Mountain View in Mountain View, California. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Murase to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Murase practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Murase's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Murase is board certified in dermatology by the American Board of Dermatology. Dr. Murase is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and hives among the conditions Dr. Murase treats.

CMS data shows 4,363 Medicare services from Dr. Murase across 16 procedure codes in 2024, for 438 Medicare patients. Medicare paid $160,075 for them. Every service was in an office.

CMS counts 438 Medicare patients who saw Dr. Murase in 2024. The largest group is 75 to 84, with 184 patients. 71% of them have high cholesterol, and 63% have high blood pressure. 10% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Murase's median patient age at 63, with 62% women.

In 2024, Dr. Murase wrote 1,661 Medicare Part D claims for 314 patients. 76% of them were for generic drugs. CMS names the drug for 1,377 of them, across 36 drugs with 11 or more claims each, at $1,292,284 in total drug cost. In 2023, CMS named 1,315 claims across 39 drugs.

Dr. Murase accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Murase as offering telehealth. CMS counts 844 procedures of removal of skin lesions by Dr. Murase, more than 92% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 98 papers to Dr. Murase, published from 2008 to 2024. 2024 was the busiest year, with 8. The most frequent topics are Dermatologic Agents, Pregnancy Complications and Dermatitis, Allergic Contact. Dr. Murase has published most often in Int J Womens Dermatol. Dr. Murase's most frequent co-authors are Jodie S. Raffi, Jashin Joaquin Wu, MD and Misha Max Heller, MD.

CMS Open Payments shows 1,084 general payments to Dr. Murase from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. UCB, Inc. paid the most, $281,467.

Dmand AI lists 2 awards for Dr. Murase, most recently CMS Stage 1 EHR in 2013.

Dr. Murase graduated from UC Irvine School of Medicine in 2003. Dr. Murase is a member of AAD.

Dr. Murase is in network with 11 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.